These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 31668346

  • 1. Risk of Atrial Fibrillation in Relation to the Time Course of Type 2 Diabetes Mellitus and Fasting Blood Glucose.
    Yang S, Choi EK, Han KD, Kwon S, Lee SY, Park J, Choi YJ, Lee HJ, Moon I, Lee E, Lee SR, Cha MJ, Lim WH, Oh S.
    Am J Cardiol; 2019 Dec 15; 124(12):1881-1888. PubMed ID: 31668346
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
    Latini R, Staszewsky L, Sun JL, Bethel MA, Disertori M, Haffner SM, Holman RR, Chang F, Giles TD, Maggioni AP, Rutten GE, Standl E, Thomas L, Tognoni G, Califf RM, McMurray JJ.
    Am Heart J; 2013 Nov 15; 166(5):935-40.e1. PubMed ID: 24176451
    [Abstract] [Full Text] [Related]

  • 4. Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan.
    Chang CY, Yeh YH, Chan YH, Liu JR, Chang SH, Lee HF, Wu LS, Yen KC, Kuo CT, See LC.
    Cardiovasc Diabetol; 2017 Dec 19; 16(1):159. PubMed ID: 29258504
    [Abstract] [Full Text] [Related]

  • 5. The impact of body weight and diabetes on new-onset atrial fibrillation: a nationwide population based study.
    Kim YG, Han KD, Choi JI, Boo KY, Kim DY, Oh SK, Lee KN, Shim J, Kim JS, Kim YH.
    Cardiovasc Diabetol; 2019 Oct 01; 18(1):128. PubMed ID: 31575379
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study.
    Eroglu TE, Coronel R, Souverein PC.
    Eur Heart J Cardiovasc Pharmacother; 2024 Jul 16; 10(4):289-295. PubMed ID: 38520149
    [Abstract] [Full Text] [Related]

  • 10. Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study.
    Ahn HJ, Han KD, Choi EK, Jung JH, Kwon S, Lee SR, Oh S, Lip GYH.
    Cardiovasc Diabetol; 2021 Jan 19; 20(1):20. PubMed ID: 33468142
    [Abstract] [Full Text] [Related]

  • 11. Risk of optic neuritis in type 2 diabetes mellitus: A nationwide cohort study.
    Lee GI, Han K, Park KA, Oh SY.
    J Neurol Sci; 2023 Jul 15; 450():120673. PubMed ID: 37201268
    [Abstract] [Full Text] [Related]

  • 12. Association between elevated blood glucose level and non-valvular atrial fibrillation: a report from the Guangzhou heart study.
    Fu L, Deng H, Lin WD, He SF, Liu FZ, Liu Y, Zhan XZ, Fang XH, Liao HT, Wei W, Liao ZL, Tang LH, Fu ZY, Zheng MR, Wu SL, Xue YM.
    BMC Cardiovasc Disord; 2019 Nov 28; 19(1):270. PubMed ID: 31779588
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of diabetes mellitus in patients with atrial fibrillation.
    Papazoglou AS, Kartas A, Samaras A, Vouloagkas I, Vrana E, Moysidis DV, Akrivos E, Kotzampasis G, Baroutidou A, Papanastasiou A, Liampas E, Botis M, Karagiannidis E, Stalikas N, Karvounis H, Tzikas A, Giannakoulas G.
    Cardiovasc Diabetol; 2021 Feb 11; 20(1):40. PubMed ID: 33573666
    [Abstract] [Full Text] [Related]

  • 14. Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort study in Korea.
    Lee SS, Ae Kong K, Kim D, Lim YM, Yang PS, Yi JE, Kim M, Kwon K, Bum Pyun W, Joung B, Park J.
    Eur Heart J; 2017 Sep 07; 38(34):2599-2607. PubMed ID: 28662568
    [Abstract] [Full Text] [Related]

  • 15. The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study.
    Lee JH, Han K, Huh JH.
    Cardiovasc Diabetol; 2020 Apr 01; 19(1):44. PubMed ID: 32238157
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Type 2 diabetes mellitus and atrial fibrillation: From mechanisms to clinical practice.
    Tadic M, Cuspidi C.
    Arch Cardiovasc Dis; 2015 Apr 01; 108(4):269-76. PubMed ID: 25858534
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.